Literature DB >> 17766319

On the relationship among QT interval, atrial fibrillation, and torsade de pointes.

Dan M Roden1, Prince Kannankeril, Dawood Darbar.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17766319      PMCID： PMC2599908          DOI： 10.1093/europace/eum165

Source DB:  PubMed          Journal:  Europace        ISSN： 1099-5129            Impact factor:   5.214


× No keyword cloud information.
  29 in total

Review 1.  Proarrhythmia.

Authors:  G V Naccarelli; D L Wolbrette; J C Luck
Journal:  Med Clin North Am       Date:  2001-03       Impact factor: 5.456

2.  Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

Authors:  S E Coplen; E M Antman; J A Berlin; P Hewitt; T C Chalmers
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

3.  [Ventricular tachycardia with 2 variable opposing foci].

Authors:  F Dessertenne
Journal:  Arch Mal Coeur Vaiss       Date:  1966-02

4.  Thiazide-induced hypokalemia with associated major ventricular arrhythmias. Report of a case and comment on therapeutic use of bretylium.

Authors:  P D Redleaf; I J Lerner
Journal:  JAMA       Date:  1968-11-04       Impact factor: 56.272

Review 5.  Clinical safety profile of sotalol in patients with arrhythmias.

Authors:  L F Soyka; C Wirtz; R B Spangenberg
Journal:  Am J Cardiol       Date:  1990-01-02       Impact factor: 2.778

6.  Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.

Authors:  L Køber; P E Bloch Thomsen; M Møller; C Torp-Pedersen; J Carlsen; E Sandøe; K Egstrup; E Agner; J Videbaek; B Marchant; A J Camm
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

7.  Quinidine-induced ventricular flutter and fibrillation without digitalis therapy.

Authors:  R W Koster; H J Wellens
Journal:  Am J Cardiol       Date:  1976-10       Impact factor: 2.778

8.  Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.

Authors:  D M Roden; R L Woosley; R K Primm
Journal:  Am Heart J       Date:  1986-06       Impact factor: 4.749

9.  Torsades de pointes occurring in association with terfenadine use.

Authors:  B P Monahan; C L Ferguson; E S Killeavy; B K Lloyd; J Troy; L R Cantilena
Journal:  JAMA       Date:  1990-12-05       Impact factor: 56.272

10.  Mechanisms of arsenic-induced prolongation of cardiac repolarization.

Authors:  Eckhard Ficker; Yuri A Kuryshev; Adrienne T Dennis; Carlos Obejero-Paz; Lu Wang; Peter Hawryluk; Barbara A Wible; Arthur M Brown
Journal:  Mol Pharmacol       Date:  2004-07       Impact factor: 4.436
View more
  8 in total

1.  Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.

Authors:  Prince J Kannankeril; Kris J Norris; Shannon Carter; Dan M Roden
Journal:  Heart Rhythm       Date:  2011-03-21       Impact factor: 6.343

Review 2.  Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients.

Authors:  Mark McCauley; Sharath Vallabhajosyula; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2016-03-22

3.  A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria.

Authors:  Margaret A Phillips; Julie Lotharius; Kennan Marsh; John White; Anthony Dayan; Karen L White; Jacqueline W Njoroge; Farah El Mazouni; Yanbin Lao; Sreekanth Kokkonda; Diana R Tomchick; Xiaoyi Deng; Trevor Laird; Sangeeta N Bhatia; Sandra March; Caroline L Ng; David A Fidock; Sergio Wittlin; Maria Lafuente-Monasterio; Francisco Javier Gamo Benito; Laura Maria Sanz Alonso; Maria Santos Martinez; Maria Belen Jimenez-Diaz; Santiago Ferrer Bazaga; Iñigo Angulo-Barturen; John N Haselden; James Louttit; Yi Cui; Arun Sridhar; Anna-Marie Zeeman; Clemens Kocken; Robert Sauerwein; Koen Dechering; Vicky M Avery; Sandra Duffy; Michael Delves; Robert Sinden; Andrea Ruecker; Kristina S Wickham; Rosemary Rochford; Janet Gahagen; Lalitha Iyer; Ed Riccio; Jon Mirsalis; Ian Bathhurst; Thomas Rueckle; Xavier Ding; Brice Campo; Didier Leroy; M John Rogers; Pradipsinh K Rathod; Jeremy N Burrows; Susan A Charman
Journal:  Sci Transl Med       Date:  2015-07-15       Impact factor: 17.956

Review 4.  Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies.

Authors:  Connor A Emdin; Christopher X Wong; Allan J Hsiao; Douglas G Altman; Sanne Ae Peters; Mark Woodward; Ayodele A Odutayo
Journal:  BMJ       Date:  2016-01-19

5.  Recent heart rate history affects QT interval duration in atrial fibrillation.

Authors:  Fady S Riad; Eathar Razak; Samir Saba; Alaa Shalaby; Jan Nemec
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

6.  Torsade de pointes: A nested case-control study in an integrated healthcare delivery system.

Authors:  Neha Mantri; Meng Lu; Jonathan G Zaroff; Neil Risch; Thomas Hoffmann; Akinyemi Oni-Orisan; Catherine Lee; Carlos Iribarren
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-09-21       Impact factor: 1.468

7.  Is the association of QTc with atrial fibrillation and stroke in cohort studies a matter of time?

Authors:  Navid Radnahad; Hanne Ehrlinder; Karin Leander; Johan Engdahl; Håkan Wallén; Bruna Gigante
Journal:  Open Heart       Date:  2022-09

8.  Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes.

Authors:  Elijah R Behr; Marylyn D Ritchie; Toshihiro Tanaka; Stefan Kääb; Dana C Crawford; Paola Nicoletti; Aris Floratos; Moritz F Sinner; Prince J Kannankeril; Arthur A M Wilde; Connie R Bezzina; Eric Schulze-Bahr; Sven Zumhagen; Pascale Guicheney; Nanette H Bishopric; Vanessa Marshall; Saad Shakir; Chrysoula Dalageorgou; Steve Bevan; Yalda Jamshidi; Rachel Bastiaenen; Robert J Myerburg; Jean-Jacques Schott; A John Camm; Gerhard Steinbeck; Kris Norris; Russ B Altman; Nicholas P Tatonetti; Steve Jeffery; Michiaki Kubo; Yusuke Nakamura; Yufeng Shen; Alfred L George; Dan M Roden
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.